A look at Sarepta Therapeutics Inc. — A Falling Knife

by DAN Sarepta Therapeutics Inc. ($SRPT) averages are at $40.81 (21 day SMA), $42.02 (50 day SMA), $36.57 (200 day SMA). Over the past 52 weeks SRPT has traded from a low of $23.46 to a high of $55.61. SRPT was last at $14.21 on a volume of 24,264,900. Average daily volume has been at 2,037,167.

52 Week Range $23.46-$55.61 Market Cap 470,731,435 Average Volume 2,037,167 Dividend Yield 0.00% Institutional Ownership 77.90% Insider Ownership: 9.30% Percentage of Float Short 31.30% Beta 1.00

Sarepta Therapeutics (SRPT) is down more than 60% today on news that the FDA has concerns about the trial results for an experimental muscular dystrophy drug. The stock is far below the 3rd standard deviation from the 20-day moving average. Technical traders may start looking for a bounce from these levels. However, the pipeline for SRPT is essentially empty, so any bounce is likely to be short lived. Currently, SRPT is a falling knife.

Sarepta Therapeutics Inc discovers and develops RNA-based therapeutics for the treatment of rare and infectious diseases. Its lead product candidate is eteplirsen.

Articles